Mitogen-Activated Protein Kinase 7 (MAPK7) (C-Term) Peptide

Details for Product No. ABIN697147, Supplier: Log in to see
Protein Name
  • A330097D03Rik
  • Erk3
  • Prkm4
  • p63Mapk
  • BMK1
  • ERK4
  • ERK5
  • PRKM7
  • Erk5-T
  • Bmk1
  • Erk5
  • Prkm7
  • ERK-5
  • ATMPK7
  • F8D23.5
  • F8D23_5
  • MAP kinase 7
  • mitogen-activated protein kinase 4
  • mitogen-activated protein kinase 7
  • Mapk4
  • MAPK7
  • Mapk7
  • MPK7
Protein Region
Peptide Type
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see
Specificity The synthetic peptide sequence used to generate the antibody AP7504a was selected from the C-term region of human ERK5 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Background MEK5 and ERK5, a member of the MAP kinase subfamily of the Ser/Thr protein kinases, interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. ERK5 is activated by tyrosine and threonine phosphorylation It is expressed in many adult tissues, abundantly in heart, placenta, lung, kidney and skeletal muscle, but is not detectable in liver. The second proline-rich region may interact with actin targeting the kinase to a specific location in the cell. ERK5 is autophosphorylated on threonine and tyrosine residues when the C-terminal part of the kinase, which could have a regulatory role, is absent.
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Zhou, Bao, Dixon: "Components of a new human protein kinase signal transduction pathway." in: The Journal of biological chemistry, Vol. 270, Issue 21, pp. 12665-9, 1995 (PubMed).

Lee, Ulevitch, Han: "Primary structure of BMK1: a new mammalian map kinase." in: Biochemical and biophysical research communications, Vol. 213, Issue 2, pp. 715-24, 1995 (PubMed).